세계의 양수천자침 시장 규모, 점유율, 동향 분석 : 시술별, 최종 용도별, 유형별, 지역별 전망, 예측(2023-2030년)

The Global Amniocentesis Needle Market size is expected to reach $283.8 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period.

As awareness of prenatal care and genetic testing grows and healthcare infrastructure improves, an increasing number of pregnant females in the Asia Pacific region are requesting access to advanced prenatal diagnostic services, such as amniocentesis. Consequently, the Asia pacific region would acquire nearly 28% of the total market share by 2030. Improved access to healthcare facilities and prenatal care services enables individuals to undergo comprehensive prenatal screening and diagnostic procedures to assess fetal health and detect genetic abnormalities.

Genetic disorders are becoming more prevalent due to various factors, including environmental factors, lifestyle changes, and increased exposure to mutagens. Moreover, advances in medical technology have made amniocentesis procedures safer, more accurate, and less invasive, thereby increasing its acceptance among pregnant individuals. Therefore, the rising incidence of genetic disorders is driving the growth of the market. Additionally, Government initiatives often aim to make prenatal screening and diagnostic procedures more accessible and affordable to pregnant individuals. Furthermore, governments often regulate the healthcare industry to ensure the safety and efficacy of medical devices and procedures. Therefore, increasing government initiatives and policies are driving the market's growth.

Moreover, during the height of the pandemic, many healthcare facilities faced disruptions in their normal operations. Non-urgent medical procedures, including some prenatal diagnostic tests like amniocentesis, were postponed or canceled to prioritize resources for COVID-19 patients. However, the market exhibited resilience and adaptability in the face of the obstacles presented by the pandemic. Manufacturers and healthcare providers implemented innovative solutions to address supply chain disruptions, enhance safety protocols, and prioritize patient care. Thus, the COVID-19 pandemic moderately impacted the market.

However, to acquire an amniotic fluid sample for genetic testing, amniocentesis requires the insertion of a catheter through the lining of the abdomen and into the amniotic sac. Moreover, amniocentesis carries a risk of infection, albeit low, due to the introduction of a foreign object (the needle) into the amniotic sac. Therefore, the risk of procedure-related complications is hampering the growth of the market.

By Procedure Analysis

On the basis of procedure, the market is segmented into amniocentesis procedures, amnioreduction procedures, fetal blood transfusion, amnioinfusion procedures, and cordocentesis procedure. In 2022, the fetal blood transfusion segment attained 27% revenue share in the market. Fetal anemia, distinguished by an inadequate quantity of red blood cells in the fetus, may arise from many causes, including alloimmune disorders or genetic anomalies. The incidence of fetal anemia may be increasing due to factors such as changes in maternal-fetal blood group incompatibilities, maternal health conditions, and environmental factors, driving the need for fetal blood transfusions.

By End-use Analysis

Based on end-use, the market is categorized into hospitals, diagnostics centers, clinics, and others. The clinics segment witnessed a 20% revenue share in the market in 2022. Clinics, especially those specializing in women's health and reproductive medicine, provide accessible and convenient healthcare services for pregnant individuals seeking prenatal screening and diagnostic procedures, including amniocentesis. Most clinics are often located in community settings, making them easily accessible to patients seeking comprehensive prenatal care.

By Type Analysis

Based on type, the market is divided into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The smaller than 100 mm segment attained a 18% revenue share in the market in 2022. and tissue damage associated with larger needle sizes. Smaller needles enhance procedural safety and reduce the likelihood of adverse events during amniocentesis procedures by minimizing tissue trauma and needle deflection, improving patient outcomes and procedural success rates.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 35% revenue share in the market in 2022. North America has witnessed a trend of increasing maternal age, with more women choosing to delay childbirth until later in life. Increased maternal age is correlated with a heightened likelihood of chromosomal defects and genetic disorders developing in fetuses; consequently, prenatal diagnostic procedures, including amniocentesis, are in greater demand as they evaluate the health and genetic status of the fetus.

List of Key Companies Profiled

• BIOPSYBELL S.R.L.
• Cook Medical, Inc. (Cook Group)
• Ri.Mos. Srl
• CooperSurgical, Inc. (The Cooper Companies, Inc.)
• Rocket Medical plc (Roko AB)
• Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
• Moller Medical GmbH (Centrotec SE)
• Becton, Dickinson and Company

Global Amniocentesis Needle Market Report Segmentation

By Procedure

• Amniocentesis Procedures
• Fetal Blood Transfusion
• Amnioreduction Procedures
• Amnioinfusion Procedure
• Cordocentesis Procedure

By End-use

• Hospitals
• Diagnostics centers
• Clinics
• Others

By Type

• 100 to 150 mm
• Larger Than 150 mm
• Smaller Than 100 mm

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Amniocentesis Needle Market, by Procedure
  • 1.4.2Global Amniocentesis Needle Market, by End-use
  • 1.4.3Global Amniocentesis Needle Market, by Type
  • 1.4.4Global Amniocentesis Needle Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Opportunities
  • 3.2.3Market Restraints
  • 3.2.4Market Challenges
• 3.3Porter Five Forces Analysis

Chapter 4.Global Amniocentesis Needle Market, by Procedure

• 4.1Global Amniocentesis Procedures Market, by Region
• 4.2Global Fetal Blood Transfusion Market, by Region
• 4.3Global Amnioreduction Procedures Market, by Region
• 4.4Global Amnioinfusion Procedure Market, by Region
• 4.5Global Cordocentesis Procedure Market, by Region

Chapter 5.Global Amniocentesis Needle Market, by End-use

• 5.1Global Hospitals Market, by Region
• 5.2Global Diagnostics centers Market, by Region
• 5.3Global Clinics Market, by Region
• 5.4Global Others Market, by Region

Chapter 6.Global Amniocentesis Needle Market, by Type

• 6.1Global 100 to 150 mm Market, by Region
• 6.2Global Larger Than 150 mm Market, by Region
• 6.3Global Smaller Than 100 mm Market, by Region

Chapter 7.Global Amniocentesis Needle Market, by Region

• 7.1North America Amniocentesis Needle Market
  • 7.1.1North America Amniocentesis Needle Market, by Procedure
    • 7.1.1.1North America Amniocentesis Procedures Market, by Country
    • 7.1.1.2North America Fetal Blood Transfusion Market, by Country
    • 7.1.1.3North America Amnioreduction Procedures Market, by Country
    • 7.1.1.4North America Amnioinfusion Procedure Market, by Country
    • 7.1.1.5North America Cordocentesis Procedure Market, by Country
  • 7.1.2North America Amniocentesis Needle Market, by End-use
    • 7.1.2.1North America Hospitals Market, by Country
    • 7.1.2.2North America Diagnostics centers Market, by Country
    • 7.1.2.3North America Clinics Market, by Country
    • 7.1.2.4North America Others Market, by Country
  • 7.1.3North America Amniocentesis Needle Market, by Type
    • 7.1.3.1North America 100 to 150 mm Market, by Country
    • 7.1.3.2North America Larger Than 150 mm Market, by Country
    • 7.1.3.3North America Smaller Than 100 mm Market, by Country
  • 7.1.4North America Amniocentesis Needle Market, by Country
    • 7.1.4.1US Amniocentesis Needle Market
      • 7.1.4.1.1US Amniocentesis Needle Market, by Procedure
      • 7.1.4.1.2US Amniocentesis Needle Market, by End-use
      • 7.1.4.1.3US Amniocentesis Needle Market, by Type
    • 7.1.4.2Canada Amniocentesis Needle Market
      • 7.1.4.2.1Canada Amniocentesis Needle Market, by Procedure
      • 7.1.4.2.2Canada Amniocentesis Needle Market, by End-use
      • 7.1.4.2.3Canada Amniocentesis Needle Market, by Type
    • 7.1.4.3Mexico Amniocentesis Needle Market
      • 7.1.4.3.1Mexico Amniocentesis Needle Market, by Procedure
      • 7.1.4.3.2Mexico Amniocentesis Needle Market, by End-use
      • 7.1.4.3.3Mexico Amniocentesis Needle Market, by Type
    • 7.1.4.4Rest of North America Amniocentesis Needle Market
      • 7.1.4.4.1Rest of North America Amniocentesis Needle Market, by Procedure
      • 7.1.4.4.2Rest of North America Amniocentesis Needle Market, by End-use
      • 7.1.4.4.3Rest of North America Amniocentesis Needle Market, by Type
• 7.2Europe Amniocentesis Needle Market
  • 7.2.1Europe Amniocentesis Needle Market, by Procedure
    • 7.2.1.1Europe Amniocentesis Procedures Market, by Country
    • 7.2.1.2Europe Fetal Blood Transfusion Market, by Country
    • 7.2.1.3Europe Amnioreduction Procedures Market, by Country
    • 7.2.1.4Europe Amnioinfusion Procedure Market, by Country
    • 7.2.1.5Europe Cordocentesis Procedure Market, by Country
  • 7.2.2Europe Amniocentesis Needle Market, by End-use
    • 7.2.2.1Europe Hospitals Market, by Country
    • 7.2.2.2Europe Diagnostics centers Market, by Country
    • 7.2.2.3Europe Clinics Market, by Country
    • 7.2.2.4Europe Others Market, by Country
  • 7.2.3Europe Amniocentesis Needle Market, by Type
    • 7.2.3.1Europe 100 to 150 mm Market, by Country
    • 7.2.3.2Europe Larger Than 150 mm Market, by Country
    • 7.2.3.3Europe Smaller Than 100 mm Market, by Country
  • 7.2.4Europe Amniocentesis Needle Market, by Country
    • 7.2.4.1Germany Amniocentesis Needle Market
      • 7.2.4.1.1Germany Amniocentesis Needle Market, by Procedure
      • 7.2.4.1.2Germany Amniocentesis Needle Market, by End-use
      • 7.2.4.1.3Germany Amniocentesis Needle Market, by Type
    • 7.2.4.2UK Amniocentesis Needle Market
      • 7.2.4.2.1UK Amniocentesis Needle Market, by Procedure
      • 7.2.4.2.2UK Amniocentesis Needle Market, by End-use
      • 7.2.4.2.3UK Amniocentesis Needle Market, by Type
    • 7.2.4.3France Amniocentesis Needle Market
      • 7.2.4.3.1France Amniocentesis Needle Market, by Procedure
      • 7.2.4.3.2France Amniocentesis Needle Market, by End-use
      • 7.2.4.3.3France Amniocentesis Needle Market, by Type
    • 7.2.4.4Russia Amniocentesis Needle Market
      • 7.2.4.4.1Russia Amniocentesis Needle Market, by Procedure
      • 7.2.4.4.2Russia Amniocentesis Needle Market, by End-use
      • 7.2.4.4.3Russia Amniocentesis Needle Market, by Type
    • 7.2.4.5Spain Amniocentesis Needle Market
      • 7.2.4.5.1Spain Amniocentesis Needle Market, by Procedure
      • 7.2.4.5.2Spain Amniocentesis Needle Market, by End-use
      • 7.2.4.5.3Spain Amniocentesis Needle Market, by Type
    • 7.2.4.6Italy Amniocentesis Needle Market
      • 7.2.4.6.1Italy Amniocentesis Needle Market, by Procedure
      • 7.2.4.6.2Italy Amniocentesis Needle Market, by End-use
      • 7.2.4.6.3Italy Amniocentesis Needle Market, by Type
    • 7.2.4.7Rest of Europe Amniocentesis Needle Market
      • 7.2.4.7.1Rest of Europe Amniocentesis Needle Market, by Procedure
      • 7.2.4.7.2Rest of Europe Amniocentesis Needle Market, by End-use
      • 7.2.4.7.3Rest of Europe Amniocentesis Needle Market, by Type
• 7.3Asia Pacific Amniocentesis Needle Market
  • 7.3.1Asia Pacific Amniocentesis Needle Market, by Procedure
    • 7.3.1.1Asia Pacific Amniocentesis Procedures Market, by Country
    • 7.3.1.2Asia Pacific Fetal Blood Transfusion Market, by Country
    • 7.3.1.3Asia Pacific Amnioreduction Procedures Market, by Country
    • 7.3.1.4Asia Pacific Amnioinfusion Procedure Market, by Country
    • 7.3.1.5Asia Pacific Cordocentesis Procedure Market, by Country
  • 7.3.2Asia Pacific Amniocentesis Needle Market, by End-use
    • 7.3.2.1Asia Pacific HOSPITALS MARKET by Country
    • 7.3.2.2Asia Pacific Diagnostics centers Market, by Country
    • 7.3.2.3Asia Pacific Clinics Market, by Country
    • 7.3.2.4Asia Pacific Others Market, by Country
  • 7.3.3Asia Pacific Amniocentesis Needle Market, by Type
    • 7.3.3.1Asia Pacific 100 to 150 mm Market, by Country
    • 7.3.3.2Asia Pacific Larger Than 150 mm Market, by Country
    • 7.3.3.3Asia Pacific Smaller Than 100 mm Market, by Country
  • 7.3.4Asia Pacific Amniocentesis Needle Market, by Country
    • 7.3.4.1China Amniocentesis Needle Market
      • 7.3.4.1.1China Amniocentesis Needle Market, by Procedure
      • 7.3.4.1.2China Amniocentesis Needle Market, by End-use
      • 7.3.4.1.3China Amniocentesis Needle Market, by Type
    • 7.3.4.2Japan Amniocentesis Needle Market
      • 7.3.4.2.1Japan Amniocentesis Needle Market, by Procedure
      • 7.3.4.2.2Japan Amniocentesis Needle Market, by End-use
      • 7.3.4.2.3Japan Amniocentesis Needle Market, by Type
    • 7.3.4.3India Amniocentesis Needle Market
      • 7.3.4.3.1India Amniocentesis Needle Market, by Procedure
      • 7.3.4.3.2India Amniocentesis Needle Market, by End-use
      • 7.3.4.3.3India Amniocentesis Needle Market, by Type
    • 7.3.4.4South Korea Amniocentesis Needle Market
      • 7.3.4.4.1South Korea Amniocentesis Needle Market, by Procedure
      • 7.3.4.4.2South Korea Amniocentesis Needle Market, by End-use
      • 7.3.4.4.3South Korea Amniocentesis Needle Market, by Type
    • 7.3.4.5Singapore Amniocentesis Needle Market
      • 7.3.4.5.1Singapore Amniocentesis Needle Market, by Procedure
      • 7.3.4.5.2Singapore Amniocentesis Needle Market, by End-use
      • 7.3.4.5.3Singapore Amniocentesis Needle Market, by Type
    • 7.3.4.6Malaysia Amniocentesis Needle Market
      • 7.3.4.6.1Malaysia Amniocentesis Needle Market, by Procedure
      • 7.3.4.6.2Malaysia Amniocentesis Needle Market, by End-use
      • 7.3.4.6.3Malaysia Amniocentesis Needle Market, by Type
    • 7.3.4.7Rest of Asia Pacific Amniocentesis Needle Market
      • 7.3.4.7.1Rest of Asia Pacific Amniocentesis Needle Market, by Procedure
      • 7.3.4.7.2Rest of Asia Pacific Amniocentesis Needle Market, by End-use
      • 7.3.4.7.3Rest of Asia Pacific Amniocentesis Needle Market, by Type
• 7.4LAMEA Amniocentesis Needle Market
  • 7.4.1LAMEA Amniocentesis Needle Market, by Procedure
    • 7.4.1.1LAMEA Amniocentesis Procedures Market, by Country
    • 7.4.1.2LAMEA Fetal Blood Transfusion Market, by Country
    • 7.4.1.3LAMEA Amnioreduction Procedures Market, by Country
    • 7.4.1.4LAMEA Amnioinfusion Procedure Market, by Country
    • 7.4.1.5LAMEA Cordocentesis Procedure Market, by Country
  • 7.4.2LAMEA Amniocentesis Needle Market, by End-use
    • 7.4.2.1LAMEA HOSPITALS MARKET by Country
    • 7.4.2.2LAMEA Diagnostics centers Market, by Country
    • 7.4.2.3LAMEA Clinics Market, by Country
    • 7.4.2.4LAMEA Others Market, by Country
  • 7.4.3LAMEA Amniocentesis Needle Market, by Type
    • 7.4.3.1LAMEA 100 to 150 mm Market, by Country
    • 7.4.3.2LAMEA Larger Than 150 mm Market, by Country
    • 7.4.3.3LAMEA Smaller Than 100 mm Market, by Country
  • 7.4.4LAMEA Amniocentesis Needle Market, by Country
    • 7.4.4.1Brazil Amniocentesis Needle Market
      • 7.4.4.1.1Brazil Amniocentesis Needle Market, by Procedure
      • 7.4.4.1.2Brazil Amniocentesis Needle Market, by End-use
      • 7.4.4.1.3Brazil Amniocentesis Needle Market, by Type
    • 7.4.4.2Argentina Amniocentesis Needle Market
      • 7.4.4.2.1Argentina Amniocentesis Needle Market, by Procedure
      • 7.4.4.2.2Argentina Amniocentesis Needle Market, by End-use
      • 7.4.4.2.3Argentina Amniocentesis Needle Market, by Type
    • 7.4.4.3UAE Amniocentesis Needle Market
      • 7.4.4.3.1UAE Amniocentesis Needle Market, by Procedure
      • 7.4.4.3.2UAE Amniocentesis Needle Market, by End-use
      • 7.4.4.3.3UAE Amniocentesis Needle Market, by Type
    • 7.4.4.4Saudi Arabia Amniocentesis Needle Market
      • 7.4.4.4.1Saudi Arabia Amniocentesis Needle Market, by Procedure
      • 7.4.4.4.2Saudi Arabia Amniocentesis Needle Market, by End-use
      • 7.4.4.4.3Saudi Arabia Amniocentesis Needle Market, by Type
    • 7.4.4.5South Africa Amniocentesis Needle Market
      • 7.4.4.5.1South Africa Amniocentesis Needle Market, by Procedure
      • 7.4.4.5.2South Africa Amniocentesis Needle Market, by End-use
      • 7.4.4.5.3South Africa Amniocentesis Needle Market, by Type
    • 7.4.4.6Nigeria Amniocentesis Needle Market
      • 7.4.4.6.1Nigeria Amniocentesis Needle Market, by Procedure
      • 7.4.4.6.2Nigeria Amniocentesis Needle Market, by End-use
      • 7.4.4.6.3Nigeria Amniocentesis Needle Market, by Type
    • 7.4.4.7Rest of LAMEA Amniocentesis Needle Market
      • 7.4.4.7.1Rest of LAMEA Amniocentesis Needle Market, by Procedure
      • 7.4.4.7.2Rest of LAMEA Amniocentesis Needle Market, by End-use
      • 7.4.4.7.3Rest of LAMEA Amniocentesis Needle Market, by Type

Chapter 8.Company Profiles

• 8.1Biopsybell S.R.L.
  • 8.1.1Company Overview
• 8.2Ri.Mos. Srl
  • 8.2.1Company Overview
• 8.3Rocket Medical plc (Roko AB)
  • 8.3.1Company Overview
  • 8.3.2Financial Analysis
  • 8.3.3Segmental and Regional Analysis
• 8.4Cook Medical, Inc. (Cook Group)
  • 8.4.1Company Overview
  • 8.4.2SWOT Analysis
• 8.5CooperSurgical, Inc. (The Cooper Companies, Inc.)
  • 8.5.1Company Overview
  • 8.5.2Financial Analysis
  • 8.5.3Segmental and Regional Analysis
  • 8.5.4Research & Development Expense
• 8.6Argon Medical Devices, Inc. (Shandong Weigao Group Medical Polymer Company Limited)
  • 8.6.1Company Overview
  • 8.6.2Financial Analysis
• 8.7Moller Medical GmbH (Centrotec SE)
  • 8.7.1Company Overview
• 8.8Becton, Dickinson, and Company
  • 8.8.1Company Overview
  • 8.8.2Financial Analysis
  • 8.8.3Segmental and Regional Analysis
  • 8.8.4Research & Development Expense
  • 8.8.5SWOT Analysis

Chapter 9.Winning Imperatives for Amniocentesis Needle Market